GLOW Blend 70MG

$69.00

GLOW is a 3-peptide research blend combining GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg) in a single lyophilized vial.

The blend lets researchers work with three separate sequences under identical handling and storage conditions, instead of preparing three vials independently.

Researchers study GLOW in:

  • Multi-peptide interaction studies
  • Extracellular matrix and fibroblast culture models
  • Actin regulation assays
  • Comparative studies against single-peptide preparations
  • Formulation and stability research

For research use only. Not for human or veterinary use.

SKU: BBG70 Category: Tag:
WHAT’S INSIDE

WHAT’S INSIDE

The 3 Peptides — What Each One Does

Each peptide in GLOW plays a specific role in the regeneration process.

GHK-Cu · 50mg — The Core
The dominant component at 50mg. GHK-Cu is the repair signal peptide studied for collagen production, tissue rebuilding, and activation of regeneration-related genes. It gives GLOW its anti-aging and skin-focused research profile.

 

BPC-157 · 10mg TB-500 · 10mg
Known as the “body protection compound.” Studied for accelerating tissue repair, reducing inflammation, and supporting gut and tendon healing. A fragment of Thymosin Beta-4 studied for tissue flexibility, scar reduction, and support for muscle and skin recovery.

 

The 1:5:1 ratio (BPC-157 : GHK-Cu : TB-500) is designed to prioritize regeneration and collagen remodeling, while BPC-157 and TB-500 support the repair process from different pathways

PHYSICAL PROPERTIES

PHYSICAL PROPERTIES

Property Details
Form Lyophilized powder blend
Color Light blue tint
Total Weight 70mg per vial
Blend Ratio 1:5:1 — BPC-157 : GHK-Cu : TB-500
Storage Refrigerated 36–46°F (2–8°C), avoid freeze-thaw cycles, protect from light
Reconstitution Bacteriostatic or sterile water recommended
Stability 24 months lyophilized, use within 30 days after reconstitution

 

POTENTIAL SIDE EFFECTS IN RESEARCH

POTENTIAL SIDE EFFECTS IN RESEARCH

All three components of GLOW have established research safety profiles, with side effects generally reported as mild and infrequent.

Injection Site Irritation Skin Flushing or Warmth
Mild redness or swelling at the injection site. Common with peptide administration and typically resolves on its own. Temporary redness or warmth sensation in the skin. Generally short-lived and not considered serious.

 

Temporary Skin Darkening Fatigue or Lightheadedness
Mild temporary pigmentation changes have been observed in some GHK-Cu studies and are considered reversible. Occasionally reported during early research protocols and usually short-lived.

 

Copper Sensitivity (GHK-Cu) Nausea
Subjects with copper sensitivity may experience localized reactions and should be monitored appropriately. Mild nausea has occasionally been observed at higher concentrations and generally resolves without intervention.

 

No serious adverse effects have been documented at standard research concentrations for the blend’s components.

DISCLAIMER

DISCLAIMER

This product is exclusively for laboratory research. Not approved for human or veterinary use.
All products sold by Ikon Peptides are intended exclusively for in-vitro laboratory research. Not approved for human consumption or veterinary use. These statements have not been evaluated by the FDA.

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.